Applied Therapeutics (APLT) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to 0.02.
- Applied Therapeutics' Equity Ratio fell 12951.81% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 12951.81%. This contributed to the annual value of 0.66 for FY2024, which is 31029.34% up from last year.
- According to the latest figures from Q3 2025, Applied Therapeutics' Equity Ratio is 0.02, which was down 12951.81% from 0.47 recorded in Q2 2025.
- In the past 5 years, Applied Therapeutics' Equity Ratio registered a high of 0.66 during Q4 2024, and its lowest value of 0.31 during Q4 2023.
- Over the past 3 years, Applied Therapeutics' median Equity Ratio value was 0.06 (recorded in 2024), while the average stood at 0.18.
- In the last 5 years, Applied Therapeutics' Equity Ratio soared by 67054.52% in 2024 and then crashed by 12951.81% in 2025.
- Quarter analysis of 3 years shows Applied Therapeutics' Equity Ratio stood at 0.31 in 2023, then soared by 310.29% to 0.66 in 2024, then plummeted by 102.48% to 0.02 in 2025.
- Its Equity Ratio was 0.02 in Q3 2025, compared to 0.47 in Q2 2025 and 0.64 in Q1 2025.